SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001011438-16-000388
Filing Date
2016-02-12
Accepted
2016-02-12 16:03:00
Documents
2
Group Members
CADIAN CAPITAL MANAGEMENT GP LLCERIC BANNASCH

Document Format Files

Seq Description Document Type Size
1 form_sc13g-avalanche.htm SC 13G 187530
2 exhibit_99-1.htm EX-99.1 8905
  Complete submission text file 0001011438-16-000388.txt   198117
Mailing Address 535 MADISON AVENUE, 36TH FLOOR NEW YORK NY 10022
Business Address 535 MADISON AVENUE, 36TH FLOOR NEW YORK NY 10022 212-792-8800
CADIAN CAPITAL MANAGEMENT, LP (Filed by) CIK: 0001423686 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 1035 O?BRIEN DRIVE, SUITE A MENLO PARK CA 94025
Business Address 1035 O?BRIEN DRIVE, SUITE A MENLO PARK CA 94025 650-272-6269
Avalanche Biotechnologies, Inc. (Subject) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88266 | Film No.: 161418805
SIC: 2836 Biological Products, (No Diagnostic Substances)